Berelowitz Michael 4/A
4/A · Recro Pharma, Inc. · Filed May 17, 2021
Insider Transaction Report
Form 4/AAmended
Berelowitz Michael
Director
Transactions
- Award
Stock Option (right to buy)
2021-04-20+38,012→ 38,012 totalExercise: $2.60Exp: 2031-04-20→ Common Stock (38,012 underlying)
Footnotes (2)
- [F1]This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021.
- [F2]The stock option will vest on April 20, 2022.